Blood Sugar Take Care and Glucose Metabolism
Withdrawn before enrolling · Phase 2 · Has a placebo group
Conditions studied: Prediabetes
In brief
This prospective international clinical trial is a two-arm, double-blind, randomized, placebo-controlled, parallel-group, multicenter study. 112 prediabetic subjects will be randomized to Blood Sugar Take Care or placebo. Randomization will be stratified by gender. The intervention period is 12 weeks. The primary outcome is fasting glucose levels.
Key facts
- Study ID
- NCT01554020
- Run by
- NewChapter, Inc.
- People needed
- 0
- Starts
- 2012-06-01
- Expected to finish
- 2013-11-01
- Last updated by the study team
- 2013-03-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- SPRIM — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.